ACLX

NEUTRALTechnical

Arcellx, Inc.

2026-04-08

Price

$114.79

-0.01%

Score12.2Top Tier

Signals7/8 DNA1/13 Act · 0/4 Risk

SentimentNEUTRALScore: 8

Volume0.5xvs 20d avg

Analysis

Arcellx (ACLX) is exhibiting textbook institutional accumulation, hovering precisely at its recent high of $114.79 and triggering powerful SURGE and ALPHA_MALE signals. The low-volume (0.5x average) upward drift, paired with an exceptionally low annualized volatility of 1.9%, triggers the QUIET_STORM signal, pointing to high-conviction price discovery by funds absorbing supply without retail frenzy. Buoyed by a RISK_ON macro regime sparked by the US-Iran ceasefire, expanding market risk appetite is providing a strong tailwind for high-quality biotech names. The stock's ability to maintain relative strength (+0.5% vs SPY) in this environment confirms a structural institutional bid rather than speculative noise.

Fired Signals

SURGEALPHA MALEQUIET STORMSTEADY CLIMBGOLDEN CROSSBOLLINGER SQUEEZEPERFECT STACKSELLER FATIGUE

Key Takeaways

Institutional Accumulation: The QUIET_STORM and ALPHA_MALE signals on 0.5x relative volume highlight steady, under-the-radar institutional buying at recent highs.
Macro Tailwind: The RISK_ON geopolitical relief rally provides a highly supportive liquidity backdrop, allowing high-beta biotech leaders to extend their breakouts.
Risk Management: Given the abnormally low 1.9% realized volatility, the $114.29 level serves as a strict line-in-the-sand to ensure the low-volatility accumulation thesis remains intact.

← Back to 2026-04-08 View Full ACLX History →Yahoo Finance &nearr;